Name: CTXR Balance Sheet - Citius Pharmaceuticals Assets & Debt | Ledgeburg
Creator: Ledgeburg
License: https://creativecommons.org/licenses/by/4.0/
Keywords: Total Assets, Current Assets, Cash and Equivalents, Total Liabilities, Long-term Debt, Short-term Debt, Shareholders Equity, Working Capital, Book Value Per Share

JavaScript is disabled. Some features may not work properly. For the best experience, please enable JavaScript in your browser.

CTXR - Citius Pharmaceuticals, Inc.

USD | NASDAQ | Healthcare

CTXR Balance Sheet - Citius Pharmaceuticals Assets & Debt | Ledgeburg

(in millions of USD)	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016	FY2015	FY2014	FY2013	FY2012	FY2011	FY2010
Cash And Short Term Investments
Cash And Equivalents	4.3	3.3	26.5	41.7	70.1	13.9	7.9	9.2	3.2	0.3	0.7	1.6	0.0	0.1	0.0	0.0
Restricted Cash	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Short Term Investments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash And Short Term Investments	4.3	3.3	26.5	41.7	70.1	13.9	7.9	9.2	3.2	0.3	0.7	1.6	0.0	0.1	0.0
Receivables
Accounts Receivable	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Current Assets
Inventory	22.3	8.3	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Non-Current Assets
Property, Plant & Equipment Gross	-	-	-	-	-	-	-	-	0.0	0.0	-	-	-	-
Current Liabilities
Accounts Payable	13.7	4.9	2.9	1.2	1.3	1.9	2.7	1.6	0.6	0.9	0.6	0.1	-	-	0.0
Non-Current Liabilities
Long Term Debt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Common Equity
Common Stock	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	-	-	0.0	-
Supplementary Data
Total Debt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

Source: SEC EDGAR company filings. Figures as reported (US GAAP)